Bilirubin / Biliverdin axis

ID: bilirubin_biliverdin_axis

Aliases: Gilbert syndrome bilirubin axis, bilirubin-biliverdin redox cycle, UGT1A1

Type: compound

Route/form: endogenous metabolite axis; not a routine supplement route

Status: physiology_target

Evidence level: mechanistic

Best data tier: direct mechanistic; human association

Support scope: human, review/regulatory

Source types: human_association_and_preclinical, review

Linked sources: 4

Broad outcomes: Cardiovascular / lipids / blood pressure, Fat loss / metabolic health, Gut / immune / inflammation, Longevity / mitochondrial / redox

Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.

Targets / mechanism

• bilirubin-biliverdin redox cycling
• UGT1A1/Gilbert syndrome association
• PPAR-alpha and immune/redox signaling

Optimization domains

• anti aging
• metabolic
• cardiovascular health
• redox
• inflammation
• endogenous

Research basis

• Gilbert syndrome and bilirubin reviews make the axis relevant to longevity, cardiometabolic, redox, immune, and PPAR-adjacent discussions.
• This is the conceptual bridge for phycocyanobilin/spirulina discussions rather than a direct supplement protocol.
• The strongest evidence is human association plus mechanistic physiology.

Limits, risks, and missing evidence

• Gilbert syndrome is an association/physiology model, not an intervention.
• Intentionally raising bilirubin can be unsafe in liver disease, hemolysis, gallstone contexts, neonates, and drug-interaction settings.
• Mild lifelong bilirubin elevation is not equivalent to acute jaundice or supplement mimicry.

Risk flags

• physiology axis
• human association
• human association not causation
• not a protocol
• bilirubin safety context

Linked papers, labels, and reviews

1. Gilbert's syndrome and the risk of death: a population-based cohort study
   human_association_and_preclinical / pubmed_gilbert_mortality_2013
   Large observational cohort associating Gilbert syndrome/mild hyperbilirubinemia with lower all-cause mortality; association, not intervention.
2. Bilirubin as a signaling molecule
   review / pubmed_bilirubin_signaling_2020
   Review of bilirubin antioxidant, immune, endocrine, PPAR, and metabolic signaling biology.
3. The physiology of bilirubin: health and disease equilibrium
   review / pubmed_bilirubin_physiology_2023
   Review of bilirubin physiology, signaling, metabolic/cardiovascular context, and toxicity boundary.
4. Bilirubin - new insights into an old molecule
   review / pubmed_bilirubin_new_insights_2025
   Recent review of bilirubin as antioxidant, signaling, hormonal, and immunomodulatory molecule.